NCT02366143 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Bevacizumab+Paclitaxel+Carboplatin
- id
- FG000
- title
- Arm C
- description
- Atezolizumab+Bevacizumab+Paclitaxel + Carboplatin
- id
- FG001
- title
- Arm B
- description
- Atezolizumab+Paclitaxel+Carboplatin
- id
- FG002
- title
- Arm A
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 307
- group Id
- FG001
- num Subjects
- 278
- group Id
- FG002
- num Subjects
- 280
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 1
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 17
- group Id
- FG002
- num Subjects
- 22
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 6
- group Id
- FG002
- num Subjects
- 0
- type
- Sponsor request to withdraw/discontinue patient
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- type
- Increased Microscopic RBCS on Urinalysis
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Randomization Error
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- type
- PI Move and Site Closure
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Study Terminated By Sponsor
- reasons
- group Id
- FG000
- num Subjects
- 70
- group Id
- FG001
- num Subjects
- 57
- group Id
- FG002
- num Subjects
- 52
- type
- Sponsor request to withdraw/discontinue patient in survival follow up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 28
- type
- Patient moved to roll-over study
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 400
- group Id
- FG001
- num Subjects
- 400
- group Id
- FG002
- num Subjects
- 402
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 400
- group Id
- FG001
- num Subjects
- 400
- group Id
- FG002
- num Subjects
- 402
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Bevacizumab+Paclitaxel+Carboplatin
- id
- FG000
- title
- Arm C
- description
- Atezolizumab+Bevacizumab+Paclitaxel + Carboplatin
- id
- FG001
- title
- Arm B
- description
- Atezolizumab+Paclitaxel+Carboplatin
- id
- FG002
- title
- Arm A
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 307
- group Id
- FG001
- num Subjects
- 278
- group Id
- FG002
- num Subjects
- 280
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 2
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 2
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 1
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 16
- group Id
- FG001
- num Subjects
- 17
- group Id
- FG002
- num Subjects
- 22
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 6
- group Id
- FG002
- num Subjects
- 0
- type
- Sponsor request to withdraw/discontinue patient
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 1
- group Id
- FG002
- num Subjects
- 0
- type
- Increased Microscopic RBCS on Urinalysis
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- Randomization Error
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- type
- PI Move and Site Closure
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 2
- type
- Study Terminated By Sponsor
- reasons
- group Id
- FG000
- num Subjects
- 70
- group Id
- FG001
- num Subjects
- 57
- group Id
- FG002
- num Subjects
- 52
- type
- Sponsor request to withdraw/discontinue patient in survival follow up
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 28
- type
- Patient moved to roll-over study
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 400
- group Id
- FG001
- num Subjects
- 400
- group Id
- FG002
- num Subjects
- 402
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 400
- group Id
- FG001
- num Subjects
- 400
- group Id
- FG002
- num Subjects
- 402
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle